钆在脑脊液中的持续存在：终末期肾病患者的诊断陷阱。
Persistence of gadolinium in CSF: a diagnostic pitfall in patients with end-stage renal disease.
作者信息
Rai A T, Hogg J P
机构信息
Department of Radiology, West Virginia University, 2278 HSCS, Morgantown, WV 26506-9235, USA.
出版信息
AJNR Am J Neuroradiol. 2001 Aug;22(7):1357-61.
Abstract
Two dialysis-dependent patients with end-stage renal disease underwent brain and spine MR imaging a few days after having undergone gadolinium-enhanced imaging studies. Increased signal intensity in the subarachnoid space on T1-weighted and fluid-attenuated inversion recovery images was noted. Excretion of gadolinium into the CSF was proven in one case by mass spectrometry. Dialysis-dependent patients with end-stage renal disease and neurologic abnormalities often undergo contrast-enhanced MR imaging. Recognition that these patients may show increased signal intensity in the subarachnoid space because of gadolinium excretion into CSF may prevent diagnostic errors.
摘要
两名依赖透析的终末期肾病患者在接受钆增强成像检查几天后接受了脑部和脊柱磁共振成像。在T1加权像和液体衰减反转恢复像上，蛛网膜下腔信号强度增加。在一例患者中，通过质谱法证实钆排泄到脑脊液中。依赖透析的终末期肾病和神经系统异常患者经常接受对比增强磁共振成像。认识到这些患者可能由于钆排泄到脑脊液中而在蛛网膜下腔显示信号强度增加，这可能会防止诊断错误。
相似文献
1
Persistence of gadolinium in CSF: a diagnostic pitfall in patients with end-stage renal disease.
AJNR Am J Neuroradiol. 2001 Aug;22(7):1357-61.
2
Increased signal in the subarachnoid space on fluid-attenuated inversion recovery imaging associated with the clearance dynamics of gadolinium chelate: a potential diagnostic pitfall.
AJNR Am J Neuroradiol. 2007 Nov-Dec;28(10):1964-7. doi: 10.3174/ajnr.A0694. Epub 2007 Sep 24.
3
High signal in the cerebrospinal fluid following prior gadolinium administration in a patient with renal impairment.
Singapore Med J. 2007 Nov;48(11):e296-8.
4
Subarachnoid gadolinium enhancement mimicking subarachnoid hemorrhage on FLAIR MR images. Fluid-attenuated inversion recovery.
AJR Am J Roentgenol. 1999 Nov;173(5):1414-5. doi: 10.2214/ajr.173.5.10541135.
5
Visualization of intravenously administered contrast material in the CSF on fluid-attenuated inversion-recovery MR images: an in vitro and animal-model investigation.
AJNR Am J Neuroradiol. 2000 Jan;21(1):105-11.
6
Gadolinium diffusion into orbital vitreous and aqueous humor, perivascular space, and ventricles in patients with chronic renal disease.
AJR Am J Roentgenol. 2002 Nov;179(5):1350-2. doi: 10.2214/ajr.179.5.1791350.
7
Subarachnoid space disease: diagnosis with fluid-attenuated inversion-recovery MR imaging and comparison with gadolinium-enhanced spin-echo MR imaging--blinded reader study.
Radiology. 1998 Aug;208(2):417-22. doi: 10.1148/radiology.208.2.9680570.
8
Exceeding the limits of the normal blood-brain barrier: quo vadis gadolinium?
AJNR Am J Neuroradiol. 2007 Nov-Dec;28(10):1835-6. doi: 10.3174/ajnr.A0725. Epub 2007 Sep 26.
9
Misleading FLAIR imaging pattern after glioma surgery with intraoperative MRI.
Neurosurg Rev. 2016 Jan;39(1):79-85; disucssion 85-6. doi: 10.1007/s10143-015-0653-z. Epub 2015 Jul 24.
10
Signal Intensity of the Cerebrospinal Fluid after Intravenous Administration of Gadolinium-based Contrast Agents: Strong Contrast Enhancement around the Vein of Labbe.
Magn Reson Med Sci. 2019 Jul 16;18(3):194-199. doi: 10.2463/mrms.mp.2018-0043. Epub 2018 Nov 9.
引用本文的文献
1
Gadolinium-based contrast agents in children.
Pediatr Radiol. 2018 Aug;48(9):1188-1196. doi: 10.1007/s00247-018-4165-1. Epub 2018 Aug 4.
2
Distribution and chemical forms of gadolinium in the brain: a review.
Br J Radiol. 2017 Nov;90(1079):20170115. doi: 10.1259/bjr.20170115. Epub 2017 Sep 28.
3
Moderate Renal Failure Accentuates T1 Signal Enhancement in the Deep Cerebellar Nuclei of Gadodiamide-Treated Rats.
Invest Radiol. 2017 May;52(5):255-264. doi: 10.1097/RLI.0000000000000339.
4
The Cerebrovascular-Chronic Kidney Disease Connection: Perspectives and Mechanisms.
Transl Stroke Res. 2017 Feb;8(1):67-76. doi: 10.1007/s12975-016-0499-x. Epub 2016 Sep 14.
5
Importance of Contrast-Enhanced Fluid-Attenuated Inversion Recovery Magnetic Resonance Imaging in Various Intracranial Pathologic Conditions.
Korean J Radiol. 2016 Jan-Feb;17(1):127-41. doi: 10.3348/kjr.2016.17.1.127. Epub 2016 Jan 6.
6
Biodistribution of gadolinium-based contrast agents, including gadolinium deposition.
J Magn Reson Imaging. 2009 Dec;30(6):1259-67. doi: 10.1002/jmri.21969.
7
Persistence of gadolinium contrast enhancement in CSF: a possible harbinger of gadolinium neurotoxicity?
AJNR Am J Neuroradiol. 2009 Jan;30(1):E1. doi: 10.3174/ajnr.A1205. Epub 2008 Jul 17.
8
Increased signal in the subarachnoid space on fluid-attenuated inversion recovery imaging associated with the clearance dynamics of gadolinium chelate: a potential diagnostic pitfall.
AJNR Am J Neuroradiol. 2007 Nov-Dec;28(10):1964-7. doi: 10.3174/ajnr.A0694. Epub 2007 Sep 24.
本文引用的文献
1
High signal in cerebrospinal fluid mimicking subarachnoid haemorrhage on FLAIR following acute stroke and intravenous contrast medium.
Neuroradiology. 2000 Aug;42(8):608-11. doi: 10.1007/s002340000347.
2
Visualization of intravenously administered contrast material in the CSF on fluid-attenuated inversion-recovery MR images: an in vitro and animal-model investigation.
AJNR Am J Neuroradiol. 2000 Jan;21(1):105-11.
3
Pharmacokinetics of 1M gadobutrol in patients with chronic renal failure.
Invest Radiol. 2000 Jan;35(1):35-40. doi: 10.1097/00004424-200001000-00004.
4
Subarachnoid gadolinium enhancement mimicking subarachnoid hemorrhage on FLAIR MR images. Fluid-attenuated inversion recovery.
AJR Am J Roentgenol. 1999 Nov;173(5):1414-5. doi: 10.2214/ajr.173.5.10541135.
5
Contrast agent neurotoxicity presenting as subarachnoid hemorrhage.
Neurology. 1999 Apr 22;52(7):1503-5. doi: 10.1212/wnl.52.7.1503.
6
Brain: gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging.
Radiology. 1999 Apr;211(1):257-63. doi: 10.1148/radiology.211.1.r99mr25257.
7
Pharmacokinetics, safety, and tolerability of gadoversetamide injection (OptiMARK) in subjects with central nervous system or liver pathology and varying degrees of renal function.
J Magn Reson Imaging. 1999 Feb;9(2):317-21. doi: 10.1002/(sici)1522-2586(199902)9:2<317::aid-jmri25>3.0.co;2-b.
8
Subarachnoid contrast enhancement mimicking subarachnoid hemorrhage after coronary angiography.
AJR Am J Roentgenol. 1999 Mar;172(3):831-2. doi: 10.2214/ajr.172.3.10063891.
9
[Clearance of gadolinium contrast agent by hemodialysis: in vitro and clinical studies].
Nihon Igaku Hoshasen Gakkai Zasshi. 1998 Nov;58(13):739-44.
10
Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis.
Acad Radiol. 1998 Jul;5(7):491-502. doi: 10.1016/s1076-6332(98)80191-8.
Zotero 插件